Beilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) discuss the possibility of using circRNAs as potential
therapeutic targets and biomarkers for cancer.
MicroRNAs as prognostic markers and
therapeutic targets in gliomas
current knowledge on promising lncRNAs as biomarkers and
therapeutic targets for IS exploring original
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) into
the processes of glioblastoma pathogenesis and the discovery of
novel
therapeutic targets in novel signaling
Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) therapeutic agents for COVID-19 -infected patients with carotid atherosclerosis are also proposed. Conclusions
as
therapeutic targets and agents. This review provides current knowledge about the role of mi
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to test the
therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
of lncRNAs in cancer and their potential clinical applications as diagnostic biomarkers and
therapeutic